MIAT and atherosclerosis: Furthermore, we determined that systemically delivered viral MIAT shRNA significantly reduced atherosclerosis progression in vivo and promoted plaque stability by enhancing the clearance of apoptotic cells by lesion macrophages in ApoE−/− mice.